v3.25.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Loss
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2022   186.2        
Balance at beginning of period at Dec. 31, 2022 $ 3,774.3 $ 1.9 $ 3,012.7 $ 852.5 $ (61.5) $ (31.3)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2022           (1.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Acquisition of treasury stock (in shares)           (3.3)
Acquisition of treasury stock (56.0)         $ (56.0)
Issuance of common stock (in shares)   0.8        
Exercise of stock options (in shares)           0.2
Exercise of stock options 4.2   (2.1)     $ 6.3
Compensatory awards released from restriction (in shares)           1.1
Compensatory awards released from restriction 0.0   (24.6)     $ 24.6
Share-based compensation 46.7   46.7      
Foreign currency translation equity adjustment 12.8       12.8  
Change in fair value of derivative instruments, net of tax 1.2       1.2  
Impact from dissolution of foreign subsidiary 0.0          
Net income (loss) 95.0     95.0    
Balance at end of period (in shares) at Dec. 31, 2023   187.0        
Balance at end of period at Dec. 31, 2023 3,878.2 $ 1.9 3,032.7 947.5 (47.5) $ (56.4)
Treasury stock, balance at end of period (in shares) at Dec. 31, 2023           (3.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Acquisition of treasury stock (in shares)           (2.0)
Acquisition of treasury stock (31.4)         $ (31.4)
Acquisition of common stock (in shares)   (0.8)        
Exercise of stock options 0.1         $ 0.1
Compensatory awards released from restriction (in shares)           2.2
Compensatory awards released from restriction 0.0   (36.9)     $ 36.9
Share-based compensation 37.0   37.0      
Foreign currency translation equity adjustment (32.8)       (32.8)  
Change in fair value of derivative instruments, net of tax 0.9       0.9  
Impact from dissolution of foreign subsidiary 3.4       3.4  
Net income (loss) (1,447.7)     (1,447.7)    
Balance at end of period (in shares) at Dec. 31, 2024   186.2        
Balance at end of period at Dec. 31, 2024 $ 2,407.7 $ 1.9 3,032.8 (500.2) (76.0) $ (50.8)
Treasury stock, balance at end of period (in shares) at Dec. 31, 2024 (3.1)         (3.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Acquisition of treasury stock (in shares)           (0.5)
Acquisition of treasury stock $ (3.7)         $ (3.7)
Exercise of stock options (in shares) 0.0          
Exercise of stock options $ 0.1         $ 0.1
Compensatory awards released from restriction (in shares)           1.3
Compensatory awards released from restriction 0.0   (21.0)     $ 21.0
Share-based compensation 25.7   25.7      
Foreign currency translation equity adjustment 40.6       40.6  
Change in fair value of derivative instruments, net of tax (6.0)       (6.0)  
Impact from dissolution of foreign subsidiary 13.8       13.8  
Net income (loss) (409.3)     (409.3)    
Balance at end of period (in shares) at Dec. 31, 2025   186.2        
Balance at end of period at Dec. 31, 2025 $ 2,068.9 $ 1.9 $ 3,037.5 $ (909.5) $ (27.6) $ (33.4)
Treasury stock, balance at end of period (in shares) at Dec. 31, 2025 (2.3)         (2.3)